Cargando…

JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1

BH3 interacting-domain death agonist (Bid) is a BH3-only pro-apoptotic member of the Bcl-2 family of proteins. Its function in apoptosis is associated with the proteolytic cleavage to the truncated form tBid, mainly by caspase-8. tBid translocates to mitochondria and assists Bax and Bak in induction...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakasam, A, Ghose, S, Oleinik, N V, Bethard, J R, Peterson, Y K, Krupenko, N I, Krupenko, S A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123105/
https://www.ncbi.nlm.nih.gov/pubmed/25077544
http://dx.doi.org/10.1038/cddis.2014.316
_version_ 1782329458624036864
author Prakasam, A
Ghose, S
Oleinik, N V
Bethard, J R
Peterson, Y K
Krupenko, N I
Krupenko, S A
author_facet Prakasam, A
Ghose, S
Oleinik, N V
Bethard, J R
Peterson, Y K
Krupenko, N I
Krupenko, S A
author_sort Prakasam, A
collection PubMed
description BH3 interacting-domain death agonist (Bid) is a BH3-only pro-apoptotic member of the Bcl-2 family of proteins. Its function in apoptosis is associated with the proteolytic cleavage to the truncated form tBid, mainly by caspase-8. tBid translocates to mitochondria and assists Bax and Bak in induction of apoptosis. c-Jun N-terminal kinase (JNK)-dependent alternative processing of Bid to jBid was also reported. We have previously shown that the folate stress enzyme 10-formyltetrahydrofolate dehydrogenase (ALDH1L1) activates JNK1 and JNK2 in cancer cells as a pro-apoptotic response. Here we report that in PC-3 prostate cancer cells, JNK1/2 phosphorylate Bid at Thr59 within the caspase cleavage site in response to ALDH1L1. In vitro, all three JNK isoforms, JNK 1–3, phosphorylated Thr59 of Bid with JNK1 being the least active. Thr59 phosphorylation protected Bid from cleavage by caspase-8, resulting in strong accumulation of the full-length protein and its translocation to mitochondria. Interestingly, although we did not observe jBid in response to ALDH1L1 in PC-3 cells, transient expression of Bid mutants lacking the caspase-8 cleavage site resulted in strong accumulation of jBid. Of note, a T59D mutant mimicking constitutive phosphorylation revealed more profound cleavage of Bid to jBid. JNK-driven Bid accumulation had a pro-apoptotic effect in our study: small interfering RNA silencing of either JNK1/2 or Bid prevented Bid phosphorylation and accumulation, and rescued ALDH1L1-expressing cells. As full-length Bid is a weaker apoptogen than tBid, we propose that the phosphorylation of Bid by JNKs, followed by the accumulation of the full-length protein, delays attainment of apoptosis, and allows the cell to evaluate the stress and make a decision regarding the response strategy. This mechanism perhaps can be modified by the alternative cleavage of phospho-T59 Bid to jBid at some conditions.
format Online
Article
Text
id pubmed-4123105
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41231052014-08-15 JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1 Prakasam, A Ghose, S Oleinik, N V Bethard, J R Peterson, Y K Krupenko, N I Krupenko, S A Cell Death Dis Original Article BH3 interacting-domain death agonist (Bid) is a BH3-only pro-apoptotic member of the Bcl-2 family of proteins. Its function in apoptosis is associated with the proteolytic cleavage to the truncated form tBid, mainly by caspase-8. tBid translocates to mitochondria and assists Bax and Bak in induction of apoptosis. c-Jun N-terminal kinase (JNK)-dependent alternative processing of Bid to jBid was also reported. We have previously shown that the folate stress enzyme 10-formyltetrahydrofolate dehydrogenase (ALDH1L1) activates JNK1 and JNK2 in cancer cells as a pro-apoptotic response. Here we report that in PC-3 prostate cancer cells, JNK1/2 phosphorylate Bid at Thr59 within the caspase cleavage site in response to ALDH1L1. In vitro, all three JNK isoforms, JNK 1–3, phosphorylated Thr59 of Bid with JNK1 being the least active. Thr59 phosphorylation protected Bid from cleavage by caspase-8, resulting in strong accumulation of the full-length protein and its translocation to mitochondria. Interestingly, although we did not observe jBid in response to ALDH1L1 in PC-3 cells, transient expression of Bid mutants lacking the caspase-8 cleavage site resulted in strong accumulation of jBid. Of note, a T59D mutant mimicking constitutive phosphorylation revealed more profound cleavage of Bid to jBid. JNK-driven Bid accumulation had a pro-apoptotic effect in our study: small interfering RNA silencing of either JNK1/2 or Bid prevented Bid phosphorylation and accumulation, and rescued ALDH1L1-expressing cells. As full-length Bid is a weaker apoptogen than tBid, we propose that the phosphorylation of Bid by JNKs, followed by the accumulation of the full-length protein, delays attainment of apoptosis, and allows the cell to evaluate the stress and make a decision regarding the response strategy. This mechanism perhaps can be modified by the alternative cleavage of phospho-T59 Bid to jBid at some conditions. Nature Publishing Group 2014-07 2014-07-31 /pmc/articles/PMC4123105/ /pubmed/25077544 http://dx.doi.org/10.1038/cddis.2014.316 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Original Article
Prakasam, A
Ghose, S
Oleinik, N V
Bethard, J R
Peterson, Y K
Krupenko, N I
Krupenko, S A
JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1
title JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1
title_full JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1
title_fullStr JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1
title_full_unstemmed JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1
title_short JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1
title_sort jnk1/2 regulate bid by direct phosphorylation at thr59 in response to aldh1l1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123105/
https://www.ncbi.nlm.nih.gov/pubmed/25077544
http://dx.doi.org/10.1038/cddis.2014.316
work_keys_str_mv AT prakasama jnk12regulatebidbydirectphosphorylationatthr59inresponsetoaldh1l1
AT ghoses jnk12regulatebidbydirectphosphorylationatthr59inresponsetoaldh1l1
AT oleiniknv jnk12regulatebidbydirectphosphorylationatthr59inresponsetoaldh1l1
AT bethardjr jnk12regulatebidbydirectphosphorylationatthr59inresponsetoaldh1l1
AT petersonyk jnk12regulatebidbydirectphosphorylationatthr59inresponsetoaldh1l1
AT krupenkoni jnk12regulatebidbydirectphosphorylationatthr59inresponsetoaldh1l1
AT krupenkosa jnk12regulatebidbydirectphosphorylationatthr59inresponsetoaldh1l1